DONATE

Publications

by Keyword: Pulse oximetry

Tas, B, Kalk, NJ, Lozano-García, M, Rafferty, GF, Cho, PSP, Kelleher, M, Moxham, J, Strang, J, Jolley, CJ, (2022). Undetected Respiratory Depression in People with Opioid Use Disorder Drug And Alcohol Dependence 234, 109401

Background: Opioid-related deaths are increasing globally. Respiratory complications of opioid use and underlying respiratory disease in people with Opioid Use Disorder (OUD) are potential contributory factors. Individual variation in susceptibility to overdose is, however, incompletely understood. This study investigated the prevalence of respiratory depression (RD) in OUD treatment and compared this to patients with chronic obstructive pulmonary disease (COPD) of equivalent severity. We also explored the contribution of opioid agonist treatment (OAT) dosage, and type, to the prevalence of RD. Methods: There were four groups of participants: 1) OUD plus COPD (‘OUD-COPD’, n = 13); 2) OUD without COPD (‘OUD’, n = 7); 3) opioid-naïve COPD patients (‘COPD'n = 13); 4) healthy controls (‘HC'n = 7). Physiological indices, including pulse oximetry (SpO2%), end-tidal CO2 (ETCO2), transcutaneous CO2 (TcCO2), respiratory airflow and second intercostal space parasternal muscle electromyography (EMGpara), were recorded continuously over 40 min whilst awake at rest. Significant RD was defined as: SpO2%< 90% for > 10 s, ETCO2 per breath > 6.6 kPa, TcCO2 overall mean > 6 kPa, respiratory pauses > 10 s Results: At least one indicator was observed in every participant with OUD (n = 20). This compared to RD episode occurrence in only 2/7 HC and 2/13 COPD participants (p < 0.05,Fisher's exact test). The occurrence of RD was similar in OUD participants prescribed methadone (n = 6) compared to those prescribed buprenorphine (n = 12). Conclusions: Undetected RD is common in OUD cohorts receiving OAT and is significantly more severe than in opioid-naïve controls. RD can be assessed using simple objective measures. Further studies are required to determine the association between RD and overdose risk. © 2022 Elsevier B.V.

JTD Keywords: buprenorphine, comorbidity, deaths, drive, heroin, lung disease, opioid substitution treatment, opioids, overdose, pulse oximetry, respiratory depression, risk, Acute exacerbations, Comorbidity, Lung disease, Opioid substitution treatment, Opioids, Overdose, Respiratory depression


Ferrer-Lluis, I., Castillo-Escario, Y., Montserrat, J. M., Jané, R., (2019). Automatic event detector from smartphone accelerometry: Pilot mHealth study for obstructive sleep apnea monitoring at home Engineering in Medicine and Biology Society (EMBC) 41st Annual International Conference of the IEEE , IEEE (Berlín, Germany) , 4990-4993

Obstructive sleep apnea (OSA) is a common disorder with a low diagnosis ratio, leaving many patients undiagnosed and untreated. In the last decades, accelerometry has been found to be a feasible solution to obtain respiratory activity and a potential tool to monitor OSA. On the other hand, many smartphone-based systems have already been developed to propose solutions for OSA monitoring and treatment. The objective of this work was to develop an automatic event detector based on smartphone accelerometry and pulse oximetry, and to assess its ability to detect thoracic movements. It was validated with a commercial OSA monitoring system at home. Results of this preliminary pilot study showed that the proposed event detector for accelerometry signals is a feasible tool to detect abnormal respiratory events, such as apneas and hypopneas, and has potential to be included in smartphone-based systems for OSA assessment.

JTD Keywords: Sleep apnea, Detectors, Pulse oximetry, Monitoring, Manuals, Band-pass filters, Pulse oximeter